Iapyx tackles HAI (hospital-acquired infection) with new funds:
This article was originally published in Clinica
Executive Summary
San Diego, California-based developer of single-use medical devices Iapyx Medical has clinched a $9m investment from Tavistock Life Sciences, enabling the former to move ahead with its efforts to penetrate the hospital-acquired infection (HAI) market. The proceeds will be used to support product development and sales and marketing activities targeted at this market. Iapyx recently undergone a name change - it was formerly known as Medical Device Group - in line with the company's rebranding strategy. Around 4 million infections each year are acquired by patients in US hospitals, according to the US Centers for Disease Control and Prevention (CDC).